Jul 28, 2021

Lynda Cheng appointed as non-executive director (ASX Announcement)

Lynda Cheng appointed as non-executive director (ASX Announcement)

Melbourne, Australia; 28 July 2021: Starpharma Holdings Limited The Board of Starpharma (ASX: SPL, OTCQX: SPHRY) is pleased to announce the appointment of Ms Lynda Cheng as an independent non-executive director, effective 1 August 2021.  

Ms Cheng has more than 25 years of experience as a finance executive including more than 15 years at Visy Industries/Pratt Holdings and 10 years in investment banking. Ms Cheng is currently Director of Corporate Development and Mergers & Acquisitions at Visy Industries / Pratt Holdings and has held various other roles in the group including CFO. She began her career as a lawyer at Blake Dawson, before moving into investment banking with J.P. Morgan in their Melbourne, Sydney, San Francisco and New York offices.

Ms Cheng is currently a non-executive director of Export Finance Australia and a member of the Wesley College Council. Ms Cheng previously served as a member of the Australian Government's International Development Policy Expert Panel and Deputy Chair and Chair of the Finance, Audit and Risk Committee of South East Water.

Starpharma’s Chairman, Mr Rob Thomas said: “We are delighted to welcome Lynda at an exciting time for the Company. Lynda brings broad commercial and international corporate expertise as well as an extensive professional network. She has deep experience in financial services, manufacturing, innovation, technology and new market entry.”

Ms Cheng will join the Audit and Risk Committee upon her appointment.

Ms Cheng holds a Bachelor of Law (Honours) and Commerce degree majoring in actuarial studies and economics from the University of Melbourne.

Download ASX Announcement: Lynda Cheng appointed as non-executive director (PDF 520kb)

 This contains certain forward-looking statements.